Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A new approach to second-line therapy for urothelial cancer?

A new approach to second-line therapy for urothelial cancer? Lancet Oncol. 2013 Jul; 14(8):682-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.